1. Ain KB, Taylor KD et al (1997) Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82(6):1857–1862
2. Ball DW, Baylin SB et al. (2000). Medullary thyroid carcinoma. In: Braverman LE, Utiger RE (eds.) Lippincott Williams & Wilkins, Philadelphia, pp 930–943
3. Baudin E, Lumbroso J et al (1996a) Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med 37(6):912–916
4. Baudin E, Schlumberger M (2007) New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 8(2):148–156
5. Baudin E, Schlumberger M et al (1996b) Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. J Clin Endocrinol Metab 81(7):2541–2544